Back
ADMA Biologics, Inc. 10K Form
Buy
70
ADMA
ADMA Biologics, Inc.
Last Price:
$20.12
Seasonality Move:
0.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ADMA News And Ratings
See the #1 stock for the next 7 days that we like better than ADMA
ADMA Financial Statistics
Sales & Book Value
| Annual Sales: | $426.5M |
|---|---|
| Cash Flow: | $-1.1M |
| Price / Cash Flow: | 119.44 |
| Annual Sales: | $1.81 |
| Price / Book: | 10.88 |
Profitability
| EPS (TTM): | 0.85150 |
|---|---|
| Net Income (TTM): | $209.4M |
| Gross Margin: | $219.2M |
| Return on Equity: | 58.71% |
| Return on Assets: | 41.45% |
ADMA Biologics, Inc. Earnings Forecast
Key ADMA Biologics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 15 years for ADMA is 51.39%.
-
The Selling, General & Administrative Expenses for ADMA have been equal to 18.38% of Gross Profit Margin.
-
The Research & Development expenses have been 0.43% of Revenue.
-
The Interest Expense is 7.05% of Operating Income.
-
The Net Earning history of ADMA is 46.35% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 10 years.
ADMA Biologics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ADMA |
| CUSIP: | 000899 |
| Website: | admabiologics.com |
Debt
| Debt-to-Equity Ratio: | 0.19 |
|---|---|
| Current Ratio: | 7.13 |
| Quick Ratio: | 3.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 24.28 |
|---|---|
| Forward P/E Ratio: | 20.54 |
ADMA Technical Analysis vs Fundamental Analysis
Buy
70
ADMA Biologics, Inc. (ADMA)
is a Buy
Is ADMA Biologics, Inc. a Buy or a Sell?
-
ADMA Biologics, Inc. stock is rated a BuyThe current ADMA Biologics, Inc. [ADMA] share price is $19.72. The Score for ADMA is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.